After Brexafemme approval, Scynexis touts data that could broaden the antifungal’s reach
After Brexafemme approval, Scynexis touts data that could broaden the [...]
With 200M unused doses, AstraZeneca’s COVID vaccine partner Serum Institute halts production
With 200M unused doses, AstraZeneca’s COVID vaccine partner Serum Institute [...]
As US launch falters, Biogen ditches Aduhelm application in Europe
As US launch falters, Biogen ditches Aduhelm application in Europe [...]
After manufacturing hiccup, Revance set for September FDA decision on Botox rival
After manufacturing hiccup, Revance set for September FDA decision on [...]
WHO gives a thumbs up to Pfizer’s Paxlovid while scolding the company for its ‘lack of price transparency’
WHO gives a thumbs up to Pfizer’s Paxlovid while scolding [...]
‘Betrayal of public trust’: Pfizer under fire for resisting Paxlovid compulsory license
‘Betrayal of public trust’: Pfizer under fire for resisting Paxlovid [...]
Fast-growing Catalent plots $350M expansion and 1,000 new hires in US
Fast-growing Catalent plots $350M expansion and 1,000 new hires in [...]
COVID-19 vaccine sales slumping now, but analysts optimistic about rebound later this year
COVID-19 vaccine sales slumping now, but analysts optimistic about rebound [...]
J&J, Endo and McKesson settle Alabama opioid litigation for $276M
J&J, Endo and McKesson settle Alabama opioid litigation for $276M [...]
Sanofi tees off work on €400M ‘factory of the future’ in Singapore
Sanofi tees off work on €400M ‘factory of the future’ [...]